(Q38922385)

7 September 2017

title

Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer (English)

1 reference

7 September 2017

Deping Zhao

1

1 reference

7 September 2017

Yi Lu

2

1 reference

7 September 2017

Chenlu Yang

3

1 reference

7 September 2017

Xiao Zhou

4

1 reference

7 September 2017

Zhifei Xu

5

1 reference

7 September 2017

publication date

8 January 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

3637-3642

1 reference

Surgery for NSCLC in the era of personalized medicine

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Joint diseases and matrix metalloproteinases: a role for MMP-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Identification of targetable FGFR gene fusions in diverse cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-3001-Y

Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers

1 reference

12 December 2020

Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1

1 reference

12 December 2020

Non-small cell lung cancer invasion and metastasis promoted by MMP-26.

1 reference

12 December 2020

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression

1 reference

12 December 2020

Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.

1 reference

12 December 2020

Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling.

1 reference

12 December 2020

Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas

1 reference

12 December 2020

Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors

1 reference

12 December 2020

Peaking of MMP-26 and TIMP-4 marks invasive transition in prostate cancer

1 reference

12 December 2020

Treatment of non-small cell lung cancer (NSCLC).

1 reference

12 December 2020

10.1007/S13277-014-3001-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1039873201

0 references

1 reference